Results 111 to 120 of about 11,732 (171)

Real-world implementation of a decision aid for treatment decisions in metastatic pancreatic cancer: a prospective multicenter study across expert centers. [PDF]

Oncologist
Graus MUJE, Broekman THT, van Nassau S, Pepels-Aarts N, Cirkel GA, den Dulk M, Haberkorn BCM, van Hellemond IEG, Hermans KEPE, Homs MYV, Los M, Luelmo SAC, Mulder SF, Streppel MM, Wumkes ML, Wilmink JW, de Hingh IHJT, Valkenburg-van Iersel LBJ, de Vos-Geelen J, Dutch Pancreatic Cancer Group .   +19 more
europepmc   +1 more source

Perioperative pancreatic ductal adenocarcinoma care in 2025: who needs neoadjuvant?-who needs radiation? [PDF]

Gland Surg
Sheng R, Wu Q, Lan K.
europepmc   +1 more source

Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Population-Based Study. [PDF]

Gut Liver
Son K, Park BK, Park CS, Han JH, Lee KJ.
europepmc   +1 more source

Adjuvant FOLFIRINOX versus S-1 monotherapy for resected PDAC: retrospective real-world data. [PDF]

Ther Adv Med Oncol
Tang H, Li Z, You T, Ying J, Cheng Y, Bai C, Wang Y.   +6 more
europepmc   +1 more source

Genomic Biomarkers for First-Line Treatment Selection in Metastatic Pancreatic Ductal Adenocarcinoma: A Narrative Review. [PDF]

Cancers (Basel)
Muddasani A, Abdelnoor A, Manne A.
europepmc   +1 more source

Growth factor supportive care for chemotherapy-induced neutropenia suppresses antitumour immunity in checkpoint blockade-responsive pancreatic cancer. [PDF]

Immunother Adv
Parent BD, Kelly AE, Hoffman MT, Dougan M, Aguirre AJ, Dougan SK.   +5 more
europepmc   +1 more source

Is FOLFIRINOX more effective than gemcitabine plus nab-paclitaxel in pancreatic adenocarcinoma? -a decade of debate! [PDF]

J Gastrointest Oncol
Babiker HM.
europepmc   +1 more source

Exploring the role of immunotherapy and radiotherapy in the adjuvant landscape of resected pancreatic cancer. [PDF]

Transl Gastroenterol Hepatol
Tan HL, Zhao Y, Goh BKP, Koh YX.
europepmc   +1 more source

REG4 serves as a prognostic biomarker for pancreatic cancer with long-standing diabetes mellitus by modulating chemoresistance. [PDF]

Transl Oncol
Choi JI, Park HJ, Park H, Cho Y, Shin HS, Koh YI, Lee SY, Jang SI, Cho JH, Kim HS, Hwang HK, Rim JH, Lim JB.   +12 more
europepmc   +1 more source

Vanishing liver metastases in pancreatic cancer: A case report. [PDF]

Oncol Lett
Florou E, Ross P, Srinivasan P, Prachalias A.   +3 more
europepmc   +1 more source